0001209191-14-064790.txt : 20141024 0001209191-14-064790.hdr.sgml : 20141024 20141024181001 ACCESSION NUMBER: 0001209191-14-064790 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141022 FILED AS OF DATE: 20141024 DATE AS OF CHANGE: 20141024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NxStage Medical, Inc. CENTRAL INDEX KEY: 0001333170 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043454702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 MERRIMACK STREET CITY: LAWRENCE STATE: MA ZIP: 01843 BUSINESS PHONE: 978-687-4700 MAIL ADDRESS: STREET 1: 350 MERRIMACK STREET CITY: LAWRENCE STATE: MA ZIP: 01843 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brown Robert S. CENTRAL INDEX KEY: 0001382096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51567 FILM NUMBER: 141173243 MAIL ADDRESS: STREET 1: NXSTAGE MEDICAL INC STREET 2: 439 SOUTH UNION STREET 5TH FLOOR CITY: LAWRENCE STATE: MA ZIP: 01843 FORMER NAME: FORMER CONFORMED NAME: Brown Robert DATE OF NAME CHANGE: 20061127 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-10-22 0 0001333170 NxStage Medical, Inc. NXTM 0001382096 Brown Robert S. C/O NXSTAGE MEDICAL, INC. 350 MERRIMACK STREET LAWRENCE MA 01843 0 1 0 0 President, Kidney Care Common Stock 2014-10-22 4 M 0 1900 4.54 A 49528 D Common Stock 2014-10-22 4 S 0 1900 14.50 D 47628 D Common Stock 2014-10-23 4 M 0 43470 4.54 A 91098 D Common Stock 2014-10-23 4 S 0 43470 14.53 D 47628 D Stock Option (Right to Buy) 4.54 2014-10-22 4 M 0 1900 0.00 D 2008-04-27 2015-03-26 Common Stock 1900 43470 D Stock Option (Right to Buy) 4.54 2014-10-23 4 M 0 43470 0.00 D 2008-04-27 2015-03-26 Common Stock 43470 0 D This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2014. This represents the weighted average price for shares sold in multiple transactions at prices ranging from $14.50 to $14.72, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request. /s/ Aras Lapinskas, attorney-in-fact for Robert Brown 2014-10-24